glp-1 tirzepatide vs semaglutide comparison efficacy side effects A 72-week trial compared the two leading GLP Tirzepatide vs Semaglutide for Weight

[18] Sildenafil should be used cautiously in patients with gastroesophageal reflux disease (GERD) or hiatal hernia associated with reflux esophagitis

For individuals who cannot tolerate weight loss injections after cholecystectomy, or for whom they are unsuitable, several evidence-based alternatives exist within NHS pathways

10.1056/NEJMoa2403347 [DOI] [PubMed] [Google Scholar] 70

Most patients begin noticing some weight loss within the first few weeks of starting a GLP-1 agonist, especially as the dose is gradually increased to the optimal maintenance level

Here is what to realistically expect during the first fourteen days, along with specific guidance for each phase

How we score: Each provider is evaluated across 8 categories using our weighted scoring framework